Zhitong Finance App News, Treasure Island (603567.SH) issued an announcement. Recently, the Jixi branch of the company received the “Notice of Approval of the Marketing Application for Chemical Ingredients” for mabalosavir issued by the State Drug Administration. Mabalosavir tablets are suitable for adults and children aged 5 and above with simple influenza A and B, including previously healthy patients and patients at high risk of influenza-related complications. Mabalosavir dry suspension is suitable for pediatric patients between 1 and 12 years of age with simple influenza A and B, including previously healthy patients and patients at high risk of influenza complications.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.